Cytoki Pharma ApS: Financial statements 2020
CVR: 40594132
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Cytoki Pharma ApS (CVR 40594132) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,039,747 and a net result of DKK -6,793,432. Equity in the 2020 report amounted to DKK -9,807,511. The company had 1 employee in the financial year.
- Gross Profit
- DKK -6,039,747
- Profit/Loss
- DKK -6,793,432
- Equity
- DKK -9,807,511
- Total Assets
- DKK 7,047,931
- Employees
- 1
Official annual report
How creditworthy is Cytoki Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Cytoki Pharma ApS has published its interim report for the period June 12, 2019 – December 31, 2019.
As of August 24, 2020, Rasmus Jørgensen has left the board of directors of Cytoki Pharma ApS.
As of August 24, 2020, Susanne Jørgensen has left the board of directors of Cytoki Pharma ApS.
About Cytoki Pharma ApS
Cytoki Pharma ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2019. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CytoKi Pharma ApS. The management consists of Anders Hagstrøm. The company's owners include LUNDBECKFOND INVEST A/S, 15-Bio ApS and YSIOS Biofund III, F.C.R.E. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK -42,198,706 and a net result of DKK -43,800,007 compared with DKK -39,261,697 the year before. Equity in the 2025 report amounted to DKK 13,473,548.